Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany

**Background:** About 400,000-500,000 people are infected with hepatitis C in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of first generation protease inhibitors has significantly improved the treatment of hepatitis C genotype...

Full description

Saved in:
Bibliographic Details
Main Authors: Jona T. Stahmeyer, Svenja Schauer, Siegbert Rossol, Hans Heinrich Wedemeyer, Daniel Wirth, Florence Bianic, Christian Krauth
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2013-12-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://jheor.org/article/9870-cost-effectiveness-of-triple-therapy-with-telaprevir-for-chronic-hepatitis-c-virus-patients-in-germany
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jheor.org/article/9870-cost-effectiveness-of-triple-therapy-with-telaprevir-for-chronic-hepatitis-c-virus-patients-in-germany

Similar Items